citrulline has been researched along with monomethyl auristatin e in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Alley, SC; Benjamin, D; Carter, PJ; Gerber, HP; Grewal, IS; Hayes, B; Hernandez-Ilizaliturri, FJ; Kung-Sutherland, M; McCormick, R; McDonagh, CF; Miyamoto, J; Morris-Tilden, C; Okeley, N; Stone, I | 1 |
Alley, SC; Baker Lee, C; Benjamin, DR; Hengel, SM; Lyon, RP; Nicholas, ND; Sanderson, RJ | 1 |
Casanova, R; Gébleux, R; Neri, D; Soltermann, A; Stringhini, M | 1 |
Agarwal, P; Chen, SC; Fine, BM; Gibiansky, L; Girish, S; Jin, JY; Kågedal, M; Koppada, N; Li, C; Lu, D; Saad, O; Samineni, D; Wang, B; Wang, X; Xu, J | 1 |
Akita, RW; Caculitan, NG; Cheung, TK; Dela Cruz Chuh, J; Haley, B; Kozak, KR; Lee, BC; Liu, Y; Ma, Y; Phung, Q; Pillow, TH; Polson, AG; Sadowsky, J; Sliwkowski, MX; Zhang, D | 1 |
Fine, BM; Gillespie, WR; Girish, S; Jin, JY; Kågedal, M; Li, C; Lu, D; Samineni, D | 1 |
Chen, F; Dong, K; Dong, LH; Jiang, J; Li, L; Song, HF; Wang, L; Xu, MZ | 1 |
7 other study(ies) available for citrulline and monomethyl auristatin e
Article | Year |
---|---|
Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Citrulline; Dimerization; Dipeptides; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Dosage; Humans; Immunoconjugates; Immunoenzyme Techniques; Lymphoma, Non-Hodgkin; Lysosomes; Mice; Mice, SCID; Oligopeptides; Receptors, Complement 3d; Rituximab; Valine; Xenograft Model Antitumor Assays | 2009 |
Antibody-conjugated drug assay for protease-cleavable antibody-drug conjugates.
Topics: Animals; Biological Assay; Citrulline; Drug Stability; Female; Humans; Immunoconjugates; Oligopeptides; Papain; Rats; Valine | 2016 |
Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Citrulline; Cricetulus; Endothelium; Extracellular Matrix; Female; Humans; Immunoconjugates; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Oligopeptides; Protein Isoforms; Tenascin; Valine | 2017 |
Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Citrulline; Cohort Studies; Female; Humans; Immunoconjugates; Male; Middle Aged; Models, Biological; Neoplasms; Oligopeptides; Valine; Young Adult | 2017 |
Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Cells, Cultured; Citrulline; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Immunoconjugates; Oligopeptides; Prodrugs; Proteolysis; Valine | 2017 |
Time-to-Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine-Citrulline-Monomethylauristatin E Antibody-Drug Conjugates.
Topics: Body Weight; Citrulline; Clinical Trials as Topic; Drug Dosage Calculations; Female; Humans; Immunoconjugates; Male; Models, Biological; Neoplasms; Oligopeptides; Peripheral Nervous System Diseases; Time Factors; Valine | 2019 |
Conjugating MMAE to a novel anti-HER2 antibody for selective targeted delivery.
Topics: Animals; Antibodies, Monoclonal; Cell Proliferation; Cell Survival; Citrulline; Drug Delivery Systems; Female; Immunoconjugates; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Oligopeptides; Receptor, ErbB-2; Tumor Cells, Cultured; Valine | 2020 |